501 related articles for article (PubMed ID: 14513413)
1. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.
Bryan CJ; Prichard MN; Daily S; Jefferson G; Hartline C; Cassady KA; Hilliard L; Shimamura M
Pediatr Infect Dis J; 2008 Oct; 27(10):946-8. PubMed ID: 18776818
[TBL] [Abstract][Full Text] [Related]
3. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant.
Chan Y; Smith D; Sadlon T; Scott JX; Goldwater PN
J Paediatr Child Health; 2007 Oct; 43(10):713-5. PubMed ID: 17854459
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster in childhood.
Leung AK; Robson WL; Leong AG
J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster in a 2-year-old vaccinated against varicella.
Ulman CA; Trevino JJ; Gandhi RK
Dermatol Online J; 2014 Jan; 20(1):21259. PubMed ID: 24456962
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child.
Iyer S; Mittal MK; Hodinka RL
Ann Emerg Med; 2009 Jun; 53(6):792-5. PubMed ID: 19028409
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
12. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
Levin MJ; DeBiasi RL; Bostik V; Schmid DS
J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
[TBL] [Abstract][Full Text] [Related]
14. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
Wassilew SW
MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
[No Abstract] [Full Text] [Related]
15. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
[TBL] [Abstract][Full Text] [Related]
16. [Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus].
Christensen CL; Poulsen A; Böttiger B; Kirk M; Andersen HK; Schmiegelow K
Ugeskr Laeger; 1999 Feb; 161(6):794-6. PubMed ID: 10068350
[TBL] [Abstract][Full Text] [Related]
17. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
Lässker U; Harder TC; Hufnagel M; Suttorp M
Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
[TBL] [Abstract][Full Text] [Related]
18. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
